Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva to begin new Laquinimod Phase III trial
Globes, Israel
Wednesday, March 6, 2013 - 11:05am
tags:
Teva, laquinimod, multiple sclerosis
SJ Strategic Investments LLC announces acquisition of securities of Tribute Pharmaceuticals Inc. By SJ Strategic Investments LLC
Sacramento Bee, CA
Wednesday, March 6, 2013 - 11:02am
tags:
Tribute Pharmaceuticals
Dr. Reddy's labs launches generic Zometa in US
Pharmaceutical Business Review
Wednesday, March 6, 2013 - 11:00am
tags:
Dr Reddy's, Zometa, generics
Riboxx Pharma collaborates with CNBG to evaluate potential of Riboxxim TLR3 agonist
Pharmaceutical Business Review
Wednesday, March 6, 2013 - 10:59am
tags:
Riboxx, Riboxxim, China National Biotech Group, infectious diseases
FDA Agrees that La Jolla Pharmaceutical Has Sufficient Data for Investigational New Drug Application
San Diego Business Journal, CA
Wednesday, March 6, 2013 - 10:56am
tags:
La Jolla Pharmaceutical, LJPC-501, hepatorenal syndrome
AstraZeneca Pharma hits 52-week low on promoter stake sale plan
Business Standard, India
Wednesday, March 6, 2013 - 10:54am
tags:
AstraZeneca
Par to pay $45M fine for illegal marketing
northjersey.com
Wednesday, March 6, 2013 - 10:52am
tags:
Par, legal, off-label
Biotech Tetraphase Pharmaceutical sets terms for $75 million IPO
NASDAQ
Wednesday, March 6, 2013 - 10:50am
tags:
Tetraphase Pharmaceuticals, IPOs
Nymox Pharmaceutical (NYMX +3.2%) is set to close in the green today after the company provided a positive update on Phase 2 clinical trials for NX-1207
Seeking Alpha
Wednesday, March 6, 2013 - 10:48am
tags:
NX-1207, prostate cancer, Nymox
3 Biotechs Still Burning Through Cash: Ariad Pharmaceuticals, Inc., Dynavax Technologies Corporation, MannKind Corporation
Insider Monkey
Wednesday, March 6, 2013 - 10:43am
tags:
Dynavax Technologies, MannKind, Ariad Pharmaceuticals
Is There Any Hope for Lilly?
Motley Fool
Wednesday, March 6, 2013 - 10:11am
tags:
Eli Lilly
Rigel Pharmaceuticals: 7 Reasons To Buy This $7 Drug Stock
Seeking Alpha
Wednesday, March 6, 2013 - 10:10am
tags:
Rigel Pharmaceuticals
Eli Lilly: A Bull Run Corroborated By Its Fundamentals
Seeking Alpha
Wednesday, March 6, 2013 - 10:01am
tags:
Eli Lilly
Celebrex Ruling Is A Windfall For Pfizer
Seeking Alpha
Wednesday, March 6, 2013 - 10:00am
tags:
Celebrex, Pfizer
Takeda Put Actos Sales Ahead of User Safety, Witness Says
Bloomberg
Wednesday, March 6, 2013 - 9:59am
tags:
Takeda, Actos, diabetes, type 2 diabetes
Bristol-Myers Squibb's Major Patent Expirations Weigh On Its Outlook
Seeking Alpha
Wednesday, March 6, 2013 - 9:58am
tags:
Bristol-Myers Squibb, patents
Down 27%: Impax Labs' Massive Drop
Motley Fool
Wednesday, March 6, 2013 - 9:56am
tags:
Impax Laboratories
Can Anything Stop Johnson & Johnson?
Motley Fool
Wednesday, March 6, 2013 - 9:56am
tags:
JNJ
Taking A Close Look At Bristol-Myers' Dividend
Seeking Alpha
Wednesday, March 6, 2013 - 9:55am
tags:
Bristol-Myers Squibb
4 Healthcare Stock Stories for Tuesday Investment Wellness
Wall Street Cheat Street
Wednesday, March 6, 2013 - 9:54am
tags:
JNJ, AcelRx, Herbalife, Santarus

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.